New clinical forms of hereditary apoA-I amyloidosis entail both glomerular and retinal amyloidosis
Magali Colombat(Centre Hospitalier Universitaire de Toulouse), Sophie Valleix(Délégation Paris 5), T. Frouget(Centre Hospitalier Universitaire de Rennes), François Paraf, Antoine Dürrbach(Inserm), Nathalie Quellard(Université de Poitiers), Éstelle Desport(Centre Hospitalier Universitaire de Poitiers), Pierre-Raphaël Rothschild(Inserm), Didier Samuel(Hôpital Paul-Brousse), Jean‐Claude Aldigier(Hôpital Dupuytren), Caroline Beugnet(Hôpital Necker-Enfants Malades), A. Tiple(Institut Européen De La Qualité Totale), Frank Bridoux(Université de Poitiers), Jean‐Michel Goujon(Centre Hospitalier Universitaire de Poitiers), Antoine P. Brézin(Université Paris Cité), Jean Philippe Rerolle(Hôpital Universitaire Dupuytren), Vincent Javaugue(Université de Poitiers)
Cited by 23
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
|Annals of Oncology|2015|897
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809
Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)
|American Journal of Transplantation|2010|566